GMP-Conference – a tool that will help market participants better understand the new game rules
18-20 September the II All-Russian GMP-Conference will be held in Gelendzhik, in the Congress Center «Kempinski Grand Hotel Gelendzhik». It is devoted to the current topic of inspection, compliance with the standard of Good Manufacturing Practice at pharmaceutical enterprises. The event organizers are the Minpromtorg of Russia and FSI «State Institute of Drugs and Good Practices».
According to Grigoriy Potapov, General Director of JSC «Pharmstandart», the company which is the General Partner of the event, the GMP-Conference is an open discussion platform that enables, together with authorities, professional associations and communities, to discuss practical issues arising in the process of good practices rules introducing.
The Official Partner of the event is the Moscow representative office of the pharmaceutical company «Gedeon Richter» (Hungary).
II All-Russian GMP-Conference will bring together leading experts of the pharmaceutical industry, managers and specialists of productions, representatives of line ministries and departments, associations, specialists in the field of professional development of the pharmaceutical industry staff.
«The application of GMP standards in Russia is a natural development process to ensure the competitiveness of domestic enterprises, – says Igor Krylov, Managing Director of Marathon Pharma. – The specialized conference, which focuses on the most important details of GMP standards implementation, is a tool that will allow participants to understand better the new game rules and to implement them taking into account the peculiarities of the Russian market».
The sub-holding «Marafon Pharma» includes the Joint Stock Kurgan Society of Medical Preparations and Products «Syntez», which is the event partner. Support for the conference was also provided by the companies «Valenta Farm», «Astellas Pharma», «Pharmimex».
The event program includes a significant number of sessions, panel discussions, where the approaches of regulators to inspection, the specifics of inspections will be discussed. Among the topics proposed for discussion – «GMP: inspection. EAEU GMP certificates mutual recognition mechanisms and support measures». The partner of this session is Chemical-Pharmaceutical Plant «AKRIKHIN».
«The quality of manufactured pharmaceutical products of the world standards level, increasing of the overall competitiveness of Russian production, import substitution and development of export potential – these industry priorities are highly important for the company «AKRIKHIN» as well, – said Elena Kasakina, Vice-President on production activities of JSC «AKRIKHIN». – The solution of these and many other tasks is impossible without a balanced and professional dialogue with the participation of a regulator, industry associations, manufacturers and leading experts. That is why we decided to support the II All-Russian GMP-Conference».
The first day of the conference will be culminated by a conversation about the plants of future: the trends of pharma, biotechnology design, European countries experience in serialization.
- Annual Biotechmed Forum: State Institute of Drugs and Good Practices presents survey results of drug manufacturers’ preparedness for comprehensive labeling
- The State Institute of Medicines and Good Practices concludes strategic agreements at the annual Biotechmed Forum
- Russian Ministry of Industry and Trade and State Institute of Drugs and Good Practices took part in International Conference of Drug Regulatory Authorities
- SID & GP strengthens interaction between international regulators
- Presentation at ISPE conference in Singapore